Albion Ventures sells stake in Haemostatix to Ergomed
Albion Ventures has sold its stake in Haemostatix, a topical blood clotting drug developer, to clinical development company Ergomed.
Ergomed
Albion Ventures has sold its stake in Haemostatix, a topical blood clotting drug developer, to clinical development company Ergomed.
Ergomed